Status:

COMPLETED

Pancake Oral Immunotherapy For Egg Allergy In Inducing Tolerance

Lead Sponsor:

KK Women's and Children's Hospital

Conditions:

Egg Allergy

Eligibility:

All Genders

2-15 years

Phase:

NA

Brief Summary

Oral immunotherapy (OIT) using raw/ cooked egg has good desensitisation outcomes but is associated with frequent and sometimes severe adverse events (anaphylaxis is not uncommon). OIT using baked egg ...

Eligibility Criteria

Inclusion

  • Allergic to 4.443g egg protein or less, at baseline egg open food challenge OR Convincing clinical reaction to egg within past 6 months (or failed a clinical egg food challenge in last 6 months) AND evidence of current sensitization (positive SPT or egg-specific IgE performed within the last 3 months)

Exclusion

  • Subjects meeting any of the exclusion criteria at baseline will be excluded from participation.
  • Required previous admission to an intensive care unit for management of an allergic reaction.
  • Children with a past history of egg allergy currently consuming egg-containing products other than extensively-heated egg in baked foods (e.g. biscuits, cakes).
  • Developed severe anaphylaxis to egg or egg-containing products requiring more than 2 adrenaline auto-injectors or intravenous adrenaline infusion.
  • Poorly controlled asthma within the previous 3 months (as defined by clinician judgement with reference to the ICON guidelines).
  • Moderate-severe eczema despite appropriate use of emollients (eczema is not otherwise an exclusion criteria).
  • Clinically significant chronic illness (other than asthma, rhinitis or eczema).
  • History of symptoms of eosinophilic oesophagitis, irrespective of cause.
  • Undergoing specific immunotherapy to another allergen and within the first year of treatment.
  • Receiving anti-IgE therapy, oral immunosuppressants, beta-blocker or ACE inhibitor.
  • Pregnancy.
  • Unwilling or unable to fulfil study requirements.

Key Trial Info

Start Date :

April 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 16 2025

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT07192510

Start Date

April 1 2021

End Date

April 16 2025

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

KK Women's and Children's Hospital

Singapore, Singapore